The European Life Settlement Association (ELSA) hosted the Secondary Life Markets Conference | 2025 on Monday, September 15th, 2025, in Zurich, Switzerland.
The Secondary Life Markets Conference (SLMC) is ELSA’s flagship event and the only one in Europe covering the entire range of secondary life markets. SLMC brings together industry experts to discuss the latest topics and trends impacting the capital markets participation in global secondary consumer life markets.
SLMC 25 was a one-day conference held both in-person and virtually, broadcast to our global audience, for those unable to come and join us in Zurich. Contact us to discuss attendance, speaking and sponsoring options for our future conferences.
Recordings of the conference are available for attendees of the event and ELSA members. Reach out for more information.
SLMC is the largest event in Europe that covers the entire range of secondary consumer life markets. Attendees from across the capital markets, and longevity and mortality experts, connect to discuss the themes and topics impacting the industry.
SLMC features expert speakers from academia, business, capital markets, and public policy delivering in-depth presentations and panel discussions on the most pressing issues impacting capital market participation in the longevity and mortality markets.
SLMC’s sponsor roster is a ‘who’s who’ of companies and organisations active in the secondary consumer life markets. Sponsoring the SLMC showcases your brand as a leading contributor to the advancement of our industry.
Register your interest for the Longevity & Mortality Investor Conference 2026
Bill Corry, CEO of asset manager Corry Capital and Andre Dylan Kohler, Partner at EY, get proceedings underway with a brief welcome address.
Longevity risk and mortality risk drive investment outcomes across a range of asset classes and investment strategies, but is 'life' itself an asset class? If not, why not? This panel digs into the nuances of the question in the opening session of the day.
Life expectancy reports are a foundational component of modelling longevity risk for a life settlement asset manager, but not all LE's are created equal. This panel discusses why deviations exist, and how asset managers interpret them for inclusion into their models.
In 2024, the life settlement market delivered more than $500m in additional dollars to American seniors when compared to the cash surrender value of their life insurance policy, and life settlement returns are uncorrelated to the broader capital markets. In his presentation, Bryan Nicholson, Executive Director at the Life Insurance Settlement Association, explains more about the 'win win' that the life settlement market provides for both consumers and investors.
The life settlement provider is the buyer on record of a life insurance policy on the secondary market, and the market itself continues to evolve. In his presentation, John Dallas, CEO at Berkshire Settlements, digs into some of the trends occurring currently, including increased vertical integration between provider and asset manager, and the consolidation seen in the market in the past decade or so, and the impact of these developments on the market.
Investors in the life settlement market rely on a diverse range of origination chanels when sourcing assets. This panel discusses the continued efforts to driver consumer demand for the life settlement option through innovation and market education.
The cohort of insureds in the life settlement industry began in the 1980s with those with severe health impairments, and has since changed dramatically to include individuals that are very healthy at the point of sale. This presentation discusses the demographic change and offers insights into any future trends.
In 2024, asset management firm, Conning, in partnership with ELSA, surveyed institutional investors and industry participants for the inaugural ELSA | Conning investor survey. In this presentaiton, Manu Mazumdar of Conning updates the audience with some top-level insights from the sophomore edition, which is due to publish in December 2025.
A significant amount of litigation activity in the life settlement industry relates to estate claims. In his presentation, James Westerlind of ArentFox Schiff examines the current state of some of these cases and their potential impact on the market.
The PHL Variable rehabilitation was a significant news story in the life settlement market, and, 18 months on, it is still waiting for a final decision. In his presentation, Khai LeQuang of Orrick explains what is known currently. LeQuang will also discuss some of the recent and current litigation that relates to policy charges.
As litigation activity continues to emerge in the life settlement industry, particularly with estate-driven lawsuits, investors and risk managers face increasing complexity in pricing this uncertainty. This presentation explores two actuarial frameworks for incorporating litigation risk into life settlement valuations.
Litigation activity is a constant companion to the life settlement market and takes various forms. This panel discusses the prevailing topics of the day that are, or should be, top of mind for life settlement asset managers and investors.